<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">REASON FOR VISIT</a></li><li><a href="#id2">Medications</a></li><li><a href="#id3">Encounters</a></li><li><a href="#id4">Assessments</a></li><li><a href="#id5">Plan Of Treatment</a></li><li><a href="#id6">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">REASON FOR VISIT</a></h3><div>3 month f/u, HEDIS: Controlling blood pressure 139/89 (Please be sure that she passes the BP readings to close hedis gap), HEDIS: A1C, DM eye Exam, HEDIS: Colon cancer screening</div><h3><a name="id2" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">hydroCHLOROthiazide 25 MG</td><td ID="instruction1"> Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Lisinopril 20 MG</td><td ID="instruction2">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Pravastatin Sodium 20 MG</td><td ID="instruction3">TAKE ONE TABLET BY MOUTH ONE TIME DAILY FOR 90 DAYS for 90</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication4">Ezetimibe 10 MG</td><td ID="instruction4">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication5">Omeprazole 20 MG</td><td ID="instruction5">TAKE ONE CAPSULE BY MOUTH ONE TIME DAILY for 90</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication6">Blood Glucose Monitor System w/Device</td><td ID="instruction6">as directed</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication7">Blood Glucose Test -</td><td ID="instruction7">as directed In Vitro Four times a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication8">Lancets -</td><td ID="instruction8">as directed Four times a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication9">metFORMIN HCl ER 750 MG</td><td ID="instruction9">TAKE ONE TABLET BY MOUTH ONE TIME DAILY WITH EVENING MEAL Oral for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">glipiZIDE 5 MG</td><td ID="instruction10">1 tablet Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Accu-Chek Guide -</td><td ID="instruction11">CHECK BLOOD SUGAR TWICE A DAY In Vitro for Not Available</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">OneTouch Ultra -</td><td ID="instruction12">CHECK BLOOD SUGAR TWICE A DAY In Vitro for Not Available</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Accu-Chek Guide Me w/Device</td><td ID="instruction13">CHECK BLOOD SUGAR TWICE A DAY for Not Available</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id3" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia (HCC Risk Code) E11.65 ; Diabetes Mellitus Type 2 with diabetic dyslipidemia (HCC) E11.69 ; Dyslipidemia associated with type 2 Diabetes Mellitus (RxHCC) E78.2 ; Hypertension (RxHCC) I10 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Chronic kidney disease, stage 3a (HCC) N18.31 and Malignant neoplasm of unspecified site of right female breast (HCC) C50.911</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia (HCC Risk Code) (ICD-10 - E11.65)</td><td/><td/><td><p/><p>Patient diabetes is not well controlled on  Metformin and Gliizide. Pt reluctant to start a different medication,  will increase dose of Glipizide</p><p>Educated on:</p><p>Medication compliance</p><p>Importance of blood sugar log</p><p>Blood sugar goals and Hb a1C goals</p><p>Healthy lifestyle: a carbohydrate-controlled low-fat diet and regular exercise</p><p>Foot care</p><p>Will continue to follow.</p></td></tr><tr><td ID="ref2">[REDACTED]</td><td>Diabetes Mellitus Type 2 with diabetic dyslipidemia (HCC) (ICD-10 - E11.69)</td><td/><td/><td><p>Patient diabetes is not well controlled on  Metformin and Gliizide. Pt reluctant to start a different medication,  will increase dose of Glipizide</p><p>Educated on:</p><p>Medication compliance</p><p>Importance of blood sugar log</p><p>Blood sugar goals and Hb a1C goals</p><p>Healthy lifestyle: a carbohydrate-controlled low-fat diet and regular exercise</p><p>Foot care</p><p>Will continue to follow.</p></td></tr><tr><td ID="ref3">[REDACTED]</td><td>Dyslipidemia associated with type 2 Diabetes Mellitus (RxHCC) (ICD-10 - E78.2)</td><td/><td/><td>Patient  did not tolerate Pravastatin,   and has tried several statins,  refuses to try [REDACTED] (livalo).  Will start on Ezetimibe</td></tr><tr><td ID="ref4">[REDACTED]</td><td>Hypertension (RxHCC) (ICD-10 - I10)</td><td/><td/><td><p>The patient is elevated,  pateitn state is better at home. </p><p>Advised to continue monitoring BP daily and report any consistent elevations &gt;130/80.</p><p>Discussed DASH diet and dietary sodium restrictions.</p><p>Continue dietary efforts and physical activity.</p></td></tr><tr><td ID="ref5">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td/><td><p>Patient with diabetic nephropathy</p><p>To avoid progression of kidney disease patient advised to make healthy lifestyle choices, keep blood sugar and BP well controlled, limit the amount of salt, avoid nephrotoxics and stay well hydrated.</p></td></tr><tr><td ID="ref6">[REDACTED]</td><td>Chronic kidney disease, stage 3a (HCC) (ICD-10 - N18.31)</td><td/><td/><td><p>CKD currently stable.</p><p>Advised to make healthy lifestyle choices, keep BP controlled, limit the amount of salt, maintain a healthy weight. Avoid nephrotoxics and stay well hydrated.</p><p>Anemia and bone mineral disorder screen: up to date.</p><p>Will continue to monitor microalbuminuria and GFR for progression.</p></td></tr><tr><td ID="ref7">[REDACTED]</td><td>Malignant neoplasm of unspecified site of right female breast (HCC) (ICD-10 - C50.911)</td><td>On Anastrozole</td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Other</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 08:30:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] [REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] F) <span class="bold">Acc No.</span> 52516 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED] [REDACTED]<br/><span class="bold">Account Number: </span>52516</td><td align="right"><span class="bold">Appointment Provider: </span>[REDACTED], APRN</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>75 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Structured Data: </span> Marketing Source : Other</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. 3 month f/u. 2. [REDACTED]: Controlling blood pressure 139/89 (Please be sure that she passes the BP readings to close hedis gap). 3. HEDIS: A1C, DM eye Exam. 4. HEDIS: Colon cancer screening. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking OneTouch Ultra - Strip CHECK BLOOD SUGAR TWICE A DAY In Vitro  , Taking Accu-Chek Guide Me w/Device Kit CHECK BLOOD SUGAR TWICE A DAY   , Taking Accu-Chek Guide - Strip CHECK BLOOD SUGAR TWICE A DAY In Vitro  , Taking Blood Glucose Monitor System w/Device Kit as directed   , Taking Lancets - Miscellaneous as directed  Four times a day , Taking Blood Glucose Test - Strip as directed In Vitro Four times a day , Taking glipiZIDE 5 MG Tablet 1 tablet Orally Twice a day , Taking metFORMIN HCl ER 750 MG Tablet Extended Release 24 Hour TAKE ONE TABLET BY MOUTH ONE TIME DAILY WITH EVENING MEAL Oral  , Taking Lisinopril 20 MG Tablet 1 tablet Oral Once a day , Taking hydroCHLOROthiazide 25 MG Tablet  Oral Once a day , Taking Ezetimibe 10 MG Tablet 1 tablet Orally Once a day , Not-Taking Pravastatin Sodium 20 MG Tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY FOR 90 DAYS   , Not-Taking Omeprazole 20 MG Capsule Delayed Release TAKE ONE CAPSULE BY MOUTH ONE TIME DAILY   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> <br/></td></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Diabetes Mellitus Type 2 with diabetic dyslipidemia (HCC) - E11.69   2. Type 2 diabetes mellitus with hyperglycemia (HCC Risk Code) - E11.65 (Primary)   3. Dyslipidemia associated with type 2 Diabetes Mellitus (RxHCC) - E78.2   4. Hypertension (RxHCC) - I10   5. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22   6. Chronic kidney disease, stage 3a (HCC) - N18.31   7. Malignant neoplasm of unspecified site of right female breast (HCC) - C50.911   <content><span class="bold">Notes : </span>On Anastrozole</content>   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Type 2 diabetes mellitus with hyperglycemia (HCC Risk Code)</span> <br/>Clinical Notes: <content><br/>Patient diabetes is not well controlled </content>on  Metformin and Gliizide. Pt reluctant to start a different medication,  will increase dose of Glipizide<content><br/>Educated on:<br/>Medication compliance<br/>Importance of blood sugar log<br/>Blood sugar goals and Hb a1C goals<br/>Healthy lifestyle: a carbohydrate-controlled low-fat diet and regular exercise<br/>Foot care<br/>Will continue to follow.</content>  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Diabetes Mellitus Type 2 with diabetic dyslipidemia (HCC)</span> <br/>Clinical Notes: Patient diabetes is not well controlled on  Metformin and Gliizide. Pt reluctant to start a different medication,  will increase dose of Glipizide<br/>Educated on:<br/>Medication compliance<br/>Importance of blood sugar log<br/>Blood sugar goals and Hb a1C goals<br/>Healthy lifestyle: a carbohydrate-controlled low-fat diet and regular exercise<br/>Foot care<br/>Will continue to follow.  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Dyslipidemia associated with type 2 Diabetes Mellitus (RxHCC)</span> <br/>Clinical Notes: Patient  did not tolerate Pravastatin,   and has tried several statins,  refuses to try pitavastatin (livalo).  Will start on Ezetimibe  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Hypertension (RxHCC)</span> <br/>Clinical Notes: The patient is elevated,  pateitn state is better at home. <br/>Advised to continue monitoring BP daily and report any consistent elevations &gt;130/80.<br/>Discussed DASH diet and dietary sodium restrictions.<br/>Continue dietary efforts and physical activity.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Clinical Notes: Patient with diabetic nephropathy<br/>To avoid progression of kidney disease patient advised to make healthy lifestyle choices, keep blood sugar and BP well controlled, limit the amount of salt, avoid nephrotoxics and stay well hydrated.  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Chronic kidney disease, stage 3a (HCC)</span> <br/>Clinical Notes: CKD currently stable.<br/>Advised to make healthy lifestyle choices, keep BP controlled, limit the amount of salt, maintain a healthy weight. Avoid nephrotoxics and stay well hydrated.<br/>Anemia and bone mineral disorder screen: up to date.<br/>Will continue to monitor microalbuminuria and GFR for progression.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li/></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronic signature of [REDACTED] , ARNP  on [REDACTED] 01:46 PM EDT</td></tr><tr><td valign="top">Sign off status: Pending</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span"/></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Appointment Provider:</span> [REDACTED], APRN</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 01:46 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/>
</body></html>